Languages Available
 
C

PT. Kimia Farma (Persero) Tbk [KAEF]   IDR 2.600  +30 (1,17%)


Loading...
KAEF IDR 2.600  +30 (1,17%)
Last Update 21 November 2018 04:00 PM
Open
IDR 2.560
Prev Close
IDR 2.570
Offer
IDR 2.600
Bid
IDR 2.580
Day Low
IDR 2.550
Day High
IDR 2.650
Volume
3.063 Lots (306.300 Shares)
Transaction Value (IDR)
799,75 M
Frequency
190 (Times)
EPS (IDR)
54,08
PE Ratio (ttm)
48,07 Times
Market Cap. (IDR)
14.440.400,00 M
Market Cap. Rank in Industry
#2 of 11 Companies in Pharmaceuticals
Market Cap. Rank in All Companies
#69 of 638 Companies
F
Net Foreign

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
O
Overview


PT. Kimia Farma (Persero) Tbk (KAEF) is an integrated Healthcare company. The company is engaged in in producing, processing, marketing, and distributing chemical, pharmaceutical, biologic, and other materials in Indonesia.

Subsidiary Affiliation
 
Company Name
Percentage
1.
Kimia Farma Dawaa Co Ltd
60,00 %
2.
PT Kimia Farma Trading & Distribution
99,99 %
3.
PT. Kimia Farma Apotek
99,99 %
4.
PT. Kimia Farma Sungwun Pharmacopia
75,00 %
5.
PT. Sinkona Indonesia Lestari
51,00 %
I
IPO
IPO Date04 July 2001
Offering Shares500.000.000
Company Listing5.054.000.000
Total List Shares5.554.000.000
Percentage9,00 %
Offering PriceRp 200
Fund RaisedRp 100.000.000.000
Securities Administration BureauPT. Datindo Entrycom
Lead UnderwriterPT. Danareksa Sekuritas
Listing BoardMain
No IPO bonds found
No IPO rights issue found
D
Dividend

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
G
Management
Commissioners
-
President Commissioner
Untung Suseno Sutarjo
Commissioner
Chrisma Aryani Albanjar
Commissioner
Muhammad Umar Fauzi
Independent Commissioner
Nurrachman
Independent Commissioner
Directors
-
President Director
Honesti Basyir
Director
Arief Pramuhanto
Director
I.G.N Suharta Wijaya
Director
Director
Verdi Budidarmo
Graph goes here...
S
Shareholders
No. Shareholder Name Number of Shares Total Paidup Capital Percentage
1. (Serie B) - Goverment of The Republic of Indonesia 4.999.999.999 IDR 499.999.999.900 90,02 %
2. (Serie B) - Public (each below 5%) 553.957.500 IDR 55.395.750.000 9,97 %
3. (Serie A) - Goverment of The Republic of Indonesia (Dwiwarna) 1 IDR 100 0,01 %
4. (Serie B) - Pujianto 42.500 IDR 4.250.000 0,00 %
V
Videos
IDNFinancials Video - President Director Rosman of Kimia Farma
08 April 2016 03:40 PM
JAKARTA  - Management of  state owned pharmaceutical company PT Kimia Farma Tbk is highly optimistic to reach double digit growth this year in lieu of finished project developments and support coming from government’s National Health Program (BPJS)...
IDNFinancials Video - Kimia Farmasi 2014 performance
16 April 2015 08:01 PM
JAKARTA  - According to Farida Astuti, the finance director of PT Kimia Farma Tbk (KAEF), the sales growth of the company reached for 4% in 2014. For Cost of Goods Sold, efficiency was 70% in 2013 and 69...
S
News Update
16 July 2018 09:08 AM Pefindo affirms idAA- rating for Kimia Farma
19 August 2015 01:27 PM Kimia Farma to Build New Factory in Bandung yosefardi.biz
04 January 2016 10:46 PM Kimia Farma plans to rustle up capex worth Rp1 trillion antaranews.com
10 October 2016 07:42 PM Kimia Farma builds pharmaceutical raw material factory antaranews.com
08 January 2017 11:48 PM Kimia Farma to open 100 new outlets antaranews.com
13 September 2017 05:03 PM Kimia Farma issues Rp1 Trillion MTN imq21.com
A
Announcement
Kimia Farma (Persero) distributes cash dividend amounted Rp 17.66 per share, cum April 26, 2018
2018-04-23 23:50:04
Links: [1] [2]
Kimia Farma (Persero) distributes cash dividend Rp 9.63 per share Cum April 28, 2017
2017-04-26 10:02:40
Links: [1] [2]
Kimia Farma (Persero) will hold annual shareholders' meeting on April 20, 2017
2017-03-17 14:15:47
Links: [1] [2]
Kimia Farma (Persero) pays dividend cum April 13, 2016
2016-04-11 00:33:19
Links: [1] [2]
Kimia Farma will hold annual shareholders' meeting on April 6, 2016
2016-02-22 23:50:58
Links: [1] [2] [3] [4]
S
Financial
Period Revenue Net Profit
Q3 - 2018 1.905.364 M 103.294 M
Q2 - 2018 1.911.813 M 84.786 M
Q1 - 2018 1.490.188 M 37.208 M
Q4 - 2017 1.825.504 M 134.820 M
Q3 - 2017 1.666.423 M 96.897 M
Q2 - 2017 1.437.587 M 65.879 M
Q1 - 2017 1.197.965 M 29.190 M
Q4 - 2016 1.843.760 M 93.589 M
Full financial and operational data available to our premium users. Please check our premium data introduction page to learn more about our tools.
No prospectus found